Gavin Screaton to Dengue Virus
This is a "connection" page, showing publications Gavin Screaton has written about Dengue Virus.
Connection Strength
1.511
-
Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response. Nat Immunol. 2017 Nov; 18(11):1228-1237.
Score: 0.404
-
The immunopathology of dengue and Zika virus infections. Curr Opin Immunol. 2017 10; 48:1-6.
Score: 0.399
-
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nat Commun. 2017 05 23; 8:15411.
Score: 0.395
-
Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine. J Virol. 2018 12 01; 92(23).
Score: 0.109
-
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Challenges of a Dengue Vaccine. Cold Spring Harb Perspect Biol. 2018 06 01; 10(6).
Score: 0.106
-
Recent advances in human flavivirus vaccines. Curr Opin Virol. 2017 04; 23:95-101.
Score: 0.098